{
    "clinical_study": {
        "@rank": "60484", 
        "acronym": "CONFIRM-HF", 
        "arm_group": {
            "arm_group_label": "Optivol\u00ae Device in CareLink", 
            "description": "A single cohort group of heart failure patients with already implanted Optivol\u00ae capable devices who are discharged home from the hospital"
        }, 
        "brief_summary": {
            "textblock": "A research study to determine if heart failure can be medically managed using data collected\n      from cardiac monitoring devices"
        }, 
        "brief_title": "Cardiac Compass With Optivol\u00ae to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF)", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 18 years of age\n\n          -  Admission for worsening of HF\n\n          -  Discharged to home\n\n          -  Have appropriate cardiac device with OptiVol\u00ae implanted for at least 34 days prior to\n             enrollment\n\n          -  Enrolled in Carelink\u00ae system and able to transmit data\n\n          -  Able to participate for at least 3 months\n\n        Exclusion Criteria:\n\n          -  Post heart transplant or actively listed\n\n          -  End-stage (Stage D) HF, including treatment with chronic ionotropic drugs or left\n             ventricular assist device support\n\n          -  Stage IV or V chronic renal dysfunction (GFR <25 mol/min per 1.73 M2)\n\n          -  Severe Chronic Obstructive Pulmonary Disease (COPD) requiring home oxygen\n\n          -  Severe pulmonary hypertension not due to left-sided HF"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "hospital inpatients"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02026635", 
            "org_study_id": "13P.296"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "heart failure", 
            "Optivol\u00ae cardiac device", 
            "Medtronic CareLink"
        ], 
        "lastchanged_date": "December 31, 2013", 
        "location": {
            "contact": {
                "email": "laura.vinci@jefferson.edu", 
                "last_name": "Laura Vinci, RN MBA", 
                "phone": "215-503-4883"
            }, 
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19107"
                }, 
                "name": "Thomas Jefferson University"
            }, 
            "investigator": [
                {
                    "last_name": "Paul Mather, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Raphael Bonita, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sharon Rubin, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gordon Reeves, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Cardiac Compass With Optivol\u00ae to Negate Future Inpatient Re-admissions Through Monitoring in Heart Failure Patients (CONFIRM-HF)", 
        "overall_contact": {
            "email": "david.whellan@jefferson.edu", 
            "last_name": "David J Whellan, MD MHS", 
            "phone": "215 955 2007"
        }, 
        "overall_contact_backup": {
            "email": "laura.vinci@jefferson.edu", 
            "last_name": "Laura Vinci, RN MBA", 
            "phone": "215 503 4883"
        }, 
        "overall_official": {
            "affiliation": "Thomas Jefferson University", 
            "last_name": "David J Whellan, MD MHS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assessment will be completed at time of enrollment and days 3 to 7, 14 to 21, 30 and 90 post discharge.", 
            "measure": "Physician Use of Cardiac Compass Reports to Determine HF Treatment Decisions", 
            "safety_issue": "No", 
            "time_frame": "90 days from enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02026635"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Track HF re-admissions and other clinical encounters between 30 and 90 days post discharge for HF.", 
                "measure": "Heart Failure Clinical Events", 
                "safety_issue": "No", 
                "time_frame": "90 days from enrollment"
            }, 
            {
                "description": "Assess the association between the use of Cardiac Compass Report and OptiVol\u00ae  and improved HF patient quality of life at both time points (30 and 90 days post discharge) utilizing the Kansas City Cardiomyopathy Questionnaire (KCCQ)", 
                "measure": "Assess Patient-Reported Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "90 days from enrollment"
            }
        ], 
        "source": "Thomas Jefferson University", 
        "sponsors": {
            "collaborator": {
                "agency": "Medtronic", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Thomas Jefferson University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}